Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors.

Casaos J, Huq S, Lott T, Felder R, Choi J, Gorelick N, Peters M, Xia Y, Maxwell R, Zhao T, Ji C, Simon T, Sesen J, Scotland SJ, Kast RE, Rubens J, Raabe E, Eberhart CG, Jackson EM, Brem H, Tyler B, Skuli N.

Oncotarget. 2018 Jan 3;9(8):8054-8067. doi: 10.18632/oncotarget.23883. eCollection 2018 Jan 30.

2.

Evaluation of Placental and Fetal Tissue Specimens for Zika Virus Infection - 50 States and District of Columbia, January-December, 2016.

Reagan-Steiner S, Simeone R, Simon E, Bhatnagar J, Oduyebo T, Free R, Denison AM, Rabeneck DB, Ellington S, Petersen E, Gary J, Hale G, Keating MK, Martines RB, Muehlenbachs A, Ritter J, Lee E, Davidson A, Conners E, Scotland S, Sandhu K, Bingham A, Kassens E, Smith L, St George K, Ahmad N, Tanner M, Beavers S, Miers B, VanMaldeghem K, Khan S, Rabe I, Gould C, Meaney-Delman D, Honein MA, Shieh WJ, Jamieson DJ, Fischer M, Zaki SR; U.S. Zika Pregnancy Registry Collaboration; Zika Virus Response Epidemiology and Surveillance Task Force Pathology Team.

MMWR Morb Mortal Wkly Rep. 2017 Jun 23;66(24):636-643. doi: 10.15585/mmwr.mm6624a3.

3.

Zika virus evolution and spread in the Americas.

Metsky HC, Matranga CB, Wohl S, Schaffner SF, Freije CA, Winnicki SM, West K, Qu J, Baniecki ML, Gladden-Young A, Lin AE, Tomkins-Tinch CH, Ye SH, Park DJ, Luo CY, Barnes KG, Shah RR, Chak B, Barbosa-Lima G, Delatorre E, Vieira YR, Paul LM, Tan AL, Barcellona CM, Porcelli MC, Vasquez C, Cannons AC, Cone MR, Hogan KN, Kopp EW, Anzinger JJ, Garcia KF, Parham LA, Ramírez RMG, Montoya MCM, Rojas DP, Brown CM, Hennigan S, Sabina B, Scotland S, Gangavarapu K, Grubaugh ND, Oliveira G, Robles-Sikisaka R, Rambaut A, Gehrke L, Smole S, Halloran ME, Villar L, Mattar S, Lorenzana I, Cerbino-Neto J, Valim C, Degrave W, Bozza PT, Gnirke A, Andersen KG, Isern S, Michael SF, Bozza FA, Souza TML, Bosch I, Yozwiak NL, MacInnis BL, Sabeti PC.

Nature. 2017 Jun 15;546(7658):411-415. doi: 10.1038/nature22402. Epub 2017 May 24.

4.

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism.

Farge T, Saland E, de Toni F, Aroua N, Hosseini M, Perry R, Bosc C, Sugita M, Stuani L, Fraisse M, Scotland S, Larrue C, Boutzen H, Féliu V, Nicolau-Travers ML, Cassant-Sourdy S, Broin N, David M, Serhan N, Sarry A, Tavitian S, Kaoma T, Vallar L, Iacovoni J, Linares LK, Montersino C, Castellano R, Griessinger E, Collette Y, Duchamp O, Barreira Y, Hirsch P, Palama T, Gales L, Delhommeau F, Garmy-Susini BH, Portais JC, Vergez F, Selak M, Danet-Desnoyers G, Carroll M, Récher C, Sarry JE.

Cancer Discov. 2017 Jul;7(7):716-735. doi: 10.1158/2159-8290.CD-16-0441. Epub 2017 Apr 17.

5.

Male-to-Female Sexual Transmission of Zika Virus-United States, January-April 2016.

Russell K, Hills SL, Oster AM, Porse CC, Danyluk G, Cone M, Brooks R, Scotland S, Schiffman E, Fredette C, White JL, Ellingson K, Hubbard A, Cohn A, Fischer M, Mead P, Powers AM, Brooks JT.

Clin Infect Dis. 2017 Jan 15;64(2):211-213. doi: 10.1093/cid/ciw692. Epub 2016 Oct 19.

PMID:
27986688
6.

Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.

Volpin F, Casaos J, Sesen J, Mangraviti A, Choi J, Gorelick N, Frikeche J, Lott T, Felder R, Scotland SJ, Eisinger-Mathason TSK, Brem H, Tyler B, Skuli N.

Oncogene. 2017 May 25;36(21):3037-3047. doi: 10.1038/onc.2016.457. Epub 2016 Dec 12.

PMID:
27941882
7.

The Bad, the Good and eIF3e/INT6.

Sesen J, Casaos J, Scotland SJ, Seva C, Eisinger-Mathason TS, Skuli N.

Front Biosci (Landmark Ed). 2017 Jan 1;22:1-20. Review.

PMID:
27814599
8.

Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.

Sesen J, Dahan P, Scotland SJ, Saland E, Dang VT, Lemarié A, Tyler BM, Brem H, Toulas C, Cohen-Jonathan Moyal E, Sarry JE, Skuli N.

PLoS One. 2015 Apr 13;10(4):e0123721. doi: 10.1371/journal.pone.0123721. eCollection 2015.

9.

A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia.

Saland E, Boutzen H, Castellano R, Pouyet L, Griessinger E, Larrue C, de Toni F, Scotland S, David M, Danet-Desnoyers G, Vergez F, Barreira Y, Collette Y, Récher C, Sarry JE.

Blood Cancer J. 2015 Mar 20;5:e297. doi: 10.1038/bcj.2015.19.

10.

Selected enteropathogens and clinical course in children hospitalized with severe acute gastroenteritis in Barbados.

Kumar A, Browne C, Scotland S, Krishnamurthy K, Nielsen AL.

Int J Health Sci (Qassim). 2014 Oct;8(4):409-17.

11.

Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells.

Sesen J, Cammas A, Scotland SJ, Elefterion B, Lemarié A, Millevoi S, Mathew LK, Seva C, Toulas C, Moyal EC, Skuli N.

Int J Mol Sci. 2014 Jan 29;15(2):2172-90. doi: 10.3390/ijms15022172.

12.

Sense of effort revisited: relative contributions of sensory feedback and efferent copy.

Scotland S, Adamo DE, Martin BJ.

Neurosci Lett. 2014 Feb 21;561:208-12. doi: 10.1016/j.neulet.2013.12.041. Epub 2013 Dec 25.

PMID:
24373991
13.

Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors.

Sanchez PV, Glantz ST, Scotland S, Kasner MT, Carroll M.

Leukemia. 2014 Apr;28(4):749-60. doi: 10.1038/leu.2013.202. Epub 2013 Jul 4.

PMID:
23823656
14.

Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells.

Scotland S, Saland E, Skuli N, de Toni F, Boutzen H, Micklow E, Sénégas I, Peyraud R, Peyriga L, Théodoro F, Dumon E, Martineau Y, Danet-Desnoyers G, Bono F, Rocher C, Levade T, Manenti S, Junot C, Portais JC, Alet N, Récher C, Selak MA, Carroll M, Sarry JE.

Leukemia. 2013 Nov;27(11):2129-38. doi: 10.1038/leu.2013.107. Epub 2013 Apr 9.

PMID:
23568147
15.

Upper limb kinesthetic asymmetries: gender and handedness effects.

Adamo DE, Scotland S, Martin BJ.

Neurosci Lett. 2012 May 16;516(2):188-92. doi: 10.1016/j.neulet.2012.03.077. Epub 2012 Apr 3.

PMID:
22490887
16.

Asymmetry in grasp force matching and sense of effort.

Adamo DE, Scotland S, Martin BJ.

Exp Brain Res. 2012 Mar;217(2):273-85. doi: 10.1007/s00221-011-2991-6. Epub 2012 Jan 5.

PMID:
22218499
17.

Use of gene probes and adhesion tests to characterise Escherichia coli belonging to enteropathogenic serogroups isolated in the United Kingdom.

Scotland SM, Smith HR, Cheasty T, Said B, Willshaw GA, Stokes N, Rowe B.

J Med Microbiol. 1996 Jun;44(6):438-43.

PMID:
8636961
18.

Catabolite repression of the adhesion of Vero cytotoxin-producing Escherichia coli of serogroups O157 and O111.

Nishikawa Y, Scotland SM, Smith HR, Willshaw GA, Rowe B.

Microb Pathog. 1995 Mar;18(3):223-9.

PMID:
7565016
19.
20.

Isolates of Escherichia coli O44:H18 of diverse origin are enteroaggregative.

Smith HR, Scotland SM, Willshaw GA, Rowe B, Cravioto A, Eslava C.

J Infect Dis. 1994 Dec;170(6):1610-3.

PMID:
7996006
21.

Association of enteroaggregative Escherichia coli with travellers' diarrhoea.

Scotland SM, Willshaw GA, Cheasty T, Rowe B, Hassall JE.

J Infect. 1994 Jul;29(1):115-6. No abstract available.

PMID:
7963629
23.

Prospective study of verocytotoxin-producing, enteroaggregative and diffusely adherent Escherichia coli in different diarrhoeal states.

Brook MG, Smith HR, Bannister BA, McConnell M, Chart H, Scotland SM, Sawyer A, Smith M, Rowe B.

Epidemiol Infect. 1994 Feb;112(1):63-7.

24.

Ability of human sera to neutralise the activity of Vero cytotoxins VT1, VT2 and variant forms of VT2.

Scotland SM, Said B, Thomas A, Rowe B.

FEMS Microbiol Lett. 1994 Jan 15;115(2-3):285-9.

PMID:
8138140
25.

Adhesion to and invasion of human colon carcinoma Caco-2 cells by Aeromonas strains.

Nishikawa Y, Hase A, Ogawasara J, Scotland SM, Smith HR, Kimura T.

J Med Microbiol. 1994 Jan;40(1):55-61.

PMID:
8289215
26.
27.
28.

A longitudinal study of Vero cytotoxin producing Escherichia coli in cattle calves in Sri Lanka.

Tokhi AM, Peiris JS, Scotland SM, Willshaw GA, Smith HR, Cheasty T.

Epidemiol Infect. 1993 Apr;110(2):197-208.

29.

Properties of Vero cytotoxin-producing Escherichia coli isolated from human and non-human sources.

Smith HR, Willshaw GA, Scotland SM, Thomas A, Rowe B.

Zentralbl Bakteriol. 1993 Apr;278(2-3):436-44. Review.

PMID:
8347946
30.
31.

Strains of Escherichia coli O157:H8 from human diarrhoea belong to attaching and effacing class of E coli.

Scotland SM, Willshaw GA, Cheasty T, Rowe B.

J Clin Pathol. 1992 Dec;45(12):1075-8.

32.

Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157.

Willshaw GA, Scotland SM, Smith HR, Rowe B.

J Infect Dis. 1992 Oct;166(4):797-802.

PMID:
1527414
33.

Virulence properties of Enterobacteriaceae isolated from the small intestine of children with diarrhea.

Penny ME, Scotland SM, Smith HR, McConnell MM, Knutton SK, Sack RB.

Pediatr Infect Dis J. 1992 Aug;11(8):623-30.

PMID:
1523072
34.

A method of enhancing verocytotoxin production by Escherichia coli.

al-Jumaili I, Burke DA, Scotland SM, al-Mardini H, Record CO.

FEMS Microbiol Lett. 1992 Jun 1;72(2):121-5.

PMID:
1505736
36.

Surveys of human enterotoxigenic Escherichia coli from three different geographical areas for possible colonization factors.

McConnell MM, Hibberd ML, Penny ME, Scotland SM, Cheasty T, Rowe B.

Epidemiol Infect. 1991 Jun;106(3):477-84.

38.

Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome.

Chart H, Smith HR, Scotland SM, Rowe B, Milford DV, Taylor CM.

Lancet. 1991 Jan 19;337(8734):138-40.

PMID:
1670788
39.

Properties of strains of Escherichia coli O26:H11 in relation to their enteropathogenic or enterohemorrhagic classification.

Scotland SM, Willshaw GA, Smith HR, Rowe B.

J Infect Dis. 1990 Nov;162(5):1069-74.

PMID:
2230233
40.

Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.

Kleanthous H, Smith HR, Scotland SM, Gross RJ, Rowe B, Taylor CM, Milford DV.

Arch Dis Child. 1990 Jul;65(7):722-7.

41.
42.
44.
45.

Serum killing of meningococci and several other gram-negative bacterial species is not decreased by incubating them with cytidine 5'-monophospho-N-acetyl neuraminic acid.

Fox AJ, Jones DM, Scotland SM, Rowe B, Smith A, Brown MR, Fitzgeorge RG, Baskerville A, Parsons NJ, Cole JA, et al.

Microb Pathog. 1989 Oct;7(4):317-8. No abstract available.

PMID:
2516218
46.
47.

Comparison of Vero-cytotoxin-encoding phages from Escherichia coli of human and bovine origin.

Rietra PJ, Willshaw GA, Smith HR, Field AM, Scotland SM, Rowe B.

J Gen Microbiol. 1989 Aug;135(8):2307-18.

PMID:
2699332
48.

Properties of Vero cytotoxin-producing Escherichia coli of human and animal origin belonging to serotypes other than O157:H7.

Dorn CR, Scotland SM, Smith HR, Willshaw GA, Rowe B.

Epidemiol Infect. 1989 Aug;103(1):83-95.

49.

Phage-typing of Vero-cytotoxin (VT) producing Escherichia coli O157 isolated in the United Kingdom.

Frost JA, Smith HR, Willshaw GA, Scotland SM, Gross RJ, Rowe B.

Epidemiol Infect. 1989 Aug;103(1):73-81.

Supplemental Content

Loading ...
Support Center